What is the catalog number for Caspase-6/CASP6 Rabbit Polyclonal Antibody?

The catalog number for Caspase-6/CASP6 Rabbit Polyclonal Antibody is orb137978.

What sizes are available for Caspase-6/CASP6 Rabbit Polyclonal Antibody?

Caspase-6/CASP6 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is Caspase-6/CASP6 Rabbit Polyclonal Antibody in stock?

Caspase-6/CASP6 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Caspase-6/CASP6 Rabbit Polyclonal Antibody

Product Specifications

Product Name Alternative

Caspase-6; CASP-6; 3.4.22.59; Apoptotic protease Mch-2; Caspase-6 subunit p18; Caspase-6 subunit p11; Casp6; Mch2

UniProt

O35397

Reactivity

Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence at the N-terminus of rat Caspase-6 (P18), different from the related mouse sequence by two amino acids.

Target

Caspase-6

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cancer Biology, Cell Biology, Metabolism Research, Neuroscience

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Mouse, Rat Immunohistochemistry (Frozen Section), 0.5-1μg/ml, Rat, Mouse Western blot, 0.1-0.5μg/ml, Mouse, Rat

Form

Lyophilized

Molecular Weight

35 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.